Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

FRA/5HB stock hub

FRA/5HB has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/5HBis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

Frankfurt Stock Exchange

Market data

Price

Recent price action with selectable time range.

FRA/5HBFRA/5HB

—

Loading chart…

In the news

Latest news · FRA/5HB

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E34.5

P25 n/aP50 n/aP75 n/a

ROE3.4

P25 n/aP50 n/aP75 n/a

ROIC5.1

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/5HB market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

217

Groups with data

Currency

CNY

Showing 217 of 217 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	DE
Employees	2,110
Employees Change	-2%
Employees Change Percent	-0.09
Enterprise value	EUR 789.3M
Exchange	Frankfurt Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	EUR 1B
Price	EUR 2.38
Price currency	EUR
Rev Per Employee	142,977.52x
Sic	2834
Symbol	fra/5HB
Website	https://www.3healthcare.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.9%
EV Earnings	26.8x
EV/EBIT	29.86x
EV/EBITDA	15.24x
EV/FCF	34.23x
EV/Sales	2.67x
FCF yield	2.27%
P/B ratio	1.44x
P/E ratio	34.49x
P/S ratio	3.37x
PE Ratio10 Y	37.2x
PE Ratio3 Y	34.34x
PE Ratio5 Y	46.87x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	8.93%
EBITDA Margin	16.41%
FCF margin	7.64%
Gross margin	68.29%
Gross Profit	EUR 206M
Gross Profit Growth	-9.95%
Gross Profit Growth Q	-11.87%
Gross Profit Growth3 Y	1.86%
Gross Profit Growth5 Y	6.63%
Net Income	EUR 29.5M
Net Income Growth	-43.31%
Net Income Growth Q	-18.55%
Net Income Growth3 Y	1.18%
Net Income Growth5 Y	-8.76%
Pretax Margin	9.68%
Profit Margin	9.76%
Profit Per Employee	EUR 13,960
ROA	1.94
Roa5y	2.45
ROCE	3.72
ROE	3.4
Roe5y	5.18
ROIC	5.15
Roic5y	6.61

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-1.59%
Cagr1y	-10.69%
Cagr3y	-6.5%
Cagr5y	-11.93%
Div CAGR3	17.88%
Div CAGR5	13.93%
EPS Growth	-42.93
EPS Growth Q	-17.95
EPS Growth3 Y	14.96
EPS Growth5 Y	-1.05
FCF Growth	-53.05%
OCF Growth	-35.66%
OCF Growth Q	-78.37%
OCF Growth10 Y	5.35%
OCF Growth3 Y	18.62%
Revenue Growth	-9.54x
Revenue Growth Q	-7.62x
Revenue Growth3 Y	2.37x
Revenue Growth5 Y	8.52x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.35
Assets	EUR 838.2M
Cash	EUR 303.3M
Current Assets	EUR 422.7M
Current Liabilities	EUR 113.3M
Debt	EUR 52.5M
Debt EBITDA	EUR 0.99
Debt Equity	EUR 0.07
Debt FCF	EUR 2.28
Equity	EUR 704.2M
Interest Coverage	11.49
Liabilities	EUR 134M
Long Term Assets	EUR 415.6M
Long Term Liabilities	EUR 20.7M
Net Cash	EUR 250.8M
Net Cash By Market Cap	EUR 24.69
Net Cash Growth	-9.69%
Net Debt EBITDA	EUR -5.07
Net Debt Equity	EUR -0.36
Net Debt FCF	EUR -10.88
Tangible Book Value	EUR 585.4M
Tangible Book Value Per Share	EUR 2.55

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.73
Inventory Turnover	1.48
Net Working Capital	EUR 57.9M
Quick ratio	3
Working Capital	EUR 312M
Working Capital Turnover	EUR 0.11

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.67%
Dividend Growth	-33.14%
Dividend Growth Years	0%
Dividend per share	EUR 0.12
Dividend Years	10
Dividend Yield	5.05%
Ex Div Date	2025-09-05
Last Dividend	EUR 0.05
Payout Ratio	97.31%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-14.82%
1Y total return	-10.68%
200-day SMA	2.81
3Y total return	-18.27%
50-day SMA	2.46
50-day SMA vs 200-day SMA	50under200
5Y total return	-47.01%
All Time High	9
All Time High Change	-73.56%
All Time High Date	2021-07-07
All Time Low	1.89
All Time Low Change	26.19%
All Time Low Date	2022-10-25
ATR	0.03
Ch YTD	-9.16
High	2.38
High52	3.24
High52 Date	2025-08-19
High52ch	-26.54%
Low	2.36
Low52	2.26
Low52 Date	2026-05-05
Low52ch	5.31%
Ma50ch	-3.21%
Price vs 200-day SMA	-15.15%
RSI	51.35
RSI Monthly	40.11
RSI Weekly	35.01
Sharpe ratio	-0.16x
Sortino ratio	-0.05
Total Return	5.72%
Tr YTD	-9.16
Tr1m	-0.83%
Tr1w	3.48%
Tr3m	-14.39%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 26.9M
Operating Income Growth	-42.29
Operating Income Growth Q	-25.01
Operating Income Growth3 Y	-2.2
Operating Income Growth5 Y	-3.85
Operating margin	8.93

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	83,472,963%
Net Borrowing	-6,691,054.7
Shares Insiders	62.97%
Shares Institutions	4.85%
Shares Qo Q	0.14%
Shares Yo Y	-0.67%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 23.1M
Average Volume	0x
Bv Per Share	2.98
CAPEX	EUR -30.2M
Ch10y	-30.33
Ch1m	-0.83
Ch1w	3.48
Ch1y	-14.39
Ch3m	-14.39
Ch3y	-25.95
Ch5y	-53.4
Ch6m	-21.19
Change	1.71%
Change From Open	0.85
Close	2.34
Days Gap	0.85
Depreciation Amortization	22,369,255.8
Earnings Date	2026-04-24
EBIT	EUR 26.9M
EBITDA	EUR 49.5M
EPS	EUR 0.13
F Score	4
FCF	EUR 23.1M
FCF EV Yield	2.92x
Financing CF	-63,831,163
Fiscal Year End	December
Founded	2,007
Goodwill	33,494,935.2
Graham Number	1.6003
Graham Upside	-32.76
Income Tax	EUR 4.5M
Investing CF	-18,840,701
Is Primary Listing	0
Last Earnings Date	2026-04-24
Last Report Date	2026-03-31
Last Split Date	2024-06-06
Last Split Type	Forward
Lynch Fair Value	EUR 0.35
Lynch Upside	-85.5
Ma150	2.72
Ma150ch	-12.6%
Ma20	2.32
Ma20ch	2.41%
Net CF	-30,983,268
Open	2.36
P FCF Ratio	44.06
P OCF Ratio	19.07
Payment Date	2025-10-17
Position In Range	100
Ppne	207,939,327.8
Price Date	2026-05-08
Price EBITDA	EUR 20.53
Ptbv Ratio	1.74
Relative Volume	20x
Revenue	301,682,564x
Tax By Revenue	1.5x
Tax Rate	15.51%
Tr6m	-21.19%
Z Score	7.43

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

FRA/5HB dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+5.1%

$0.12 annual per share

Payout ratio

+97.3%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+13.9%

0 consecutive years of growth

Total shareholder yield

+5.7%

Next ex-dividend date: 2025-09-05

Performance

FRA/5HB stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/5HB?

Insider, institutional, and short-interest positioning.

Institutional ownership

+4.9%

Share of float held by funds and institutions

Insider ownership

+63.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.7%

Negative means the company is buying back shares.

Technical

FRA/5HB momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

51.3

Neutral momentum band

Price vs 200-day MA

-15.2%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-0.16

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/5HB

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/5HB stock rating?

fra/5HB is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/5HB analysis?

The full report lives at /stocks/fra/5HB/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/5HB?

The latest report frames fra/5HB around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/5HB page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.